Skip to main content
Jianjun Gao, MD, Oncology, Houston, TX

JianjunGaoMD

Oncology Houston, TX

Physician

Dr. Gao is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Gao's full profile

Already have an account?

  • Office

    1515 Holcombe Blvd Unit 1374
    U Texas Md Anderson Cancer Center, Hem/Onc Dept
    Houston, TX 77030
    Phone+1 713-792-2830

Education & Training

  • University of Texas Health Science Center at Houston/M D Anderson Cancer Center
    University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2010 - 2013
  • University of Wisconsin Hospitals and Clinics
    University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 2006 - 2010
  • University of Kansas School of Medicine
    University of Kansas School of MedicineClass of 2006

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • AZ State Medical License
    AZ State Medical License 2023 - 2026
  • TN State Medical License
    TN State Medical License 2023 - 2026
  • WA State Medical License
    WA State Medical License 2023 - 2026
  • GA State Medical License
    GA State Medical License 2023 - 2025
  • LA State Medical License
    LA State Medical License 2023 - 2025
  • MS State Medical License
    MS State Medical License 2023 - 2025
  • American Board of Internal Medicine Medical Oncology
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Author Correction: Fecal Microbiota Transplantation for Refractory Immune Checkpoint Inhibitor-Associated Colitis  
    Matthew T Campbell, Jennifer A Wargo, John R Stroehlein, Padmanee Sharma, Sumit K Subudhi, Gottumukkala S Raju, Jianjun Gao, Alexander J Lazar, Dipen M Maru, Michael T..., Nature
  • Fecal Microbiota Transplantation for Refractory Immune Checkpoint Inhibitor-Associated Colitis  
    John R Stroehlein, Sumit K Subudhi, Jennifer A Wargo, Dipen M Maru, Gottumukkala S Raju, Jianjun Gao, Matthew T Campbell, Michael T Tetzlaff, Padmanee Sharma, Nature

Lectures

  • A pilot presurgical study evaluating anti-PD-L1 durvalumab (durva) plus anti-CTLA-4 tremelimumab (treme) in patients (pts) with high-risk muscle-invasive bladder carci... 
    2019 ASCO Annual Meeting - 6/1/2019
  • A pilot randomized study evaluating nivolumab (nivo) or nivo + bevacizumab (bev) or nivo + ipilimumab (ipi) in patients with metastatic renal cell carcinoma (MRCC) eli... 
    2019 ASCO Annual Meeting - 6/1/2019
  • A pilot randomized study evaluating nivolumab (nivo) or nivo + bevacizumab (bev) or nivo + ipilimumab (ipi) in patients with metastatic renal cell carcinoma (MRCC) eli... 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Press Mentions

  • Immunotherapy Clinical Trial Puts Stage IV Kidney Cancer into Remission
    Immunotherapy Clinical Trial Puts Stage IV Kidney Cancer into RemissionMarch 29th, 2023
  • MD Anderson Research Highlights for April 13, 2022
    MD Anderson Research Highlights for April 13, 2022April 13th, 2022
  • B-cell Enrichment Predictive of Immunotherapy Response in Melanoma, Sarcoma and Kidney Cancer
    B-cell Enrichment Predictive of Immunotherapy Response in Melanoma, Sarcoma and Kidney CancerFebruary 25th, 2020
  • Join now to see all

Professional Memberships